Monday, March 29, 2021
By KHRISNA RUSSELL
Tribune Chief Reporter
krussell@tribunemedia.net
MORE than 7,000 people in New Providence and Grand Bahama have received the Oxford-AstraZeneca COVID-19 vaccine with officials expecting 33,600 more doses this week.
According to the Office of the Prime Minister yesterday, the expected batch of vaccines from the World Health Organisation’s COVAX Facility represents the first tranche of 100,800 doses earmarked for The Bahamas and pre-paid through the PAHO Revolving Fund.
The statement said around 63 percent of people who have received the vaccine are age 60 and older.
Forty-two percent of people who received the vaccine were male and 58 percent are female.
The statement said vaccinations will now take place in Eleuthera this week. Grand Bahama’s vaccine programme will also resume after appointments were cancelled on Saturday due to oversubscription.
“The Bahamas has been informed by the Pan-American Health Organisation that it will receive 33,600 doses of the AstraZeneca COVID-19 vaccine through the COVAX Facility this week.
“The batch represents the first tranche of a total of 100,800 doses earmarked for The Bahamas and pre-paid through the PAHO Revolving Fund.”
The country received its first batch of COVID-19 vaccines on March 10—which were 20,000 doses of the AstraZeneca vaccine donated by the government of India.
“Since the COVID-19 vaccination programme began on March 14, 2021, more than 7,000 doses of the AstraZeneca vaccine have been administered on New Providence and Grand Bahama,” the statement said.
“The highest number of COVID-19 vaccinations administered on a single day totaled more than 1,000.
“To date, 63 percent of those who have received the vaccine are over the age of 60. Others include healthcare workers and staff of the uniformed branches. Forty-two percent of persons who received the vaccine were male and 58 percent, female.”
Vaccinations will continue on New Providence and Grand Bahama today through Wednesday, and on Eleuthera from Tuesday through Thursday.
For New Providence, vaccinations will continue for staff of the uniformed branches only on Monday and Tuesday at Loyola Hall, Gladstone Rd.
Unformed branches include the Royal Bahamas Defence Force, Royal Bahamas Police Force, COVID Ambassadors, as well as customs, immigration and correctional officers.
On Wednesday, appointments at Loyola Hall will be open to the staff of the judiciary, unformed staff branches, healthcare workers and members of the general public over the age of 60.
On Grand Bahama, the focus of the vaccination effort will be on the east and west ends of the island at the start of the week and will continue at the Susan J Wallace Community Centre, beginning mid-week.
On New Providence and Grand Bahama, mobile units will provide vaccinations to nursing homes and other residential facilities.
On the island of Eleuthera, including Harbour Island and Spanish Wells, COVID-19 vaccines will be administered starting with healthcare workers, residents over the age of 60, and staff of the uniformed branches, beginning Tuesday through Thursday.
Clinic administrators will notify residents of Eleuthera of vaccination centre locations and times.
The national vaccination programme will resume following the Easter holidays. A schedule of locations and eligible priority groups will be shared with the public in the coming days.
Residents eligible to receive the vaccine should continue to check www.doctorshosp.com/vaccine-registration.html for appointments as they become available.
Comments
tribanon says...
***Repost from earlier this afternoon:***
Provinces in Canada have just halted the use of the AstraZeneca vaccines.
According to CBC News reports this afternoon, Health Canada — which approved the AstraZeneca-Oxford COVAX vaccine for use in Canada in February — said its regulators would be adding "additional terms and conditions on the authorizations" for AstraZeneca and a biologically identical version of the drug manufactured by the Serum Institute of India, which has been branded Covishield.
Health Canada will now require the manufacturers of these AstraZeneca vaccines to conduct a "detailed assessment of the benefits and risks of the vaccine by age and sex in the Canadian context," information that could lead to "additional regulatory actions.
The press release in Canada said: "The additional information requested from the manufacturers of the AstraZeneca vaccines will be used to support the ongoing evaluation of blood clotting events, and allow Health Canada to determine if there are specific groups of people who may be at higher risk."
Apparently Health Canada has concerns about younger people under the age of 55 developing a rare type of potentially deadly blood clot. Individuals around the age of 35 may be at greatest risk, especially women.
Meanwhile, the US Food & Drug Administration still has not approved the AstraZeneca vaccines for emergency use in the US. But the Communist China controlled W.H.O. and its affiliate the P.A.H.O. nevertheless continue to maintain the AstraZeneca vaccines are safe for everyone and that seems good enough for our own health officials here in the Bahamas.
Posted 29 March 2021, 4:35 p.m. Suggest removal
Bobsyeruncle says...
**And my Repost**
My guess would be a temporary pause, similar to those also introduced by some EU countries, but then reinstated soon after.
After all, 25 cases of CVST out of 20 million shots given, is a far smaller percentage than those who die after contracting COVID.
I know you and a few others on here like to use the survival rate of COVID as your main argument against the social & economic restrictions, so using that same argument you shouldn't have an issue with the AZ vaccine, right?
Posted 29 March 2021, 5:50 p.m. Suggest removal
tribanon says...
My friend, there are many of us who have major personal issues with AstraZeneca itself as perhaps the world's most aggressive Big Pharma corporation. It has a well known history of chasing windfall profits at the expense of the health and well being of the ultimate users of its newer 'rushed-to-market' products when the opportunity arises. Its litigation track record also speaks volumes when compared to the other pharma giants, both as to the nature of the matters litigated and the settlement amounts involved.
Posted 30 March 2021, 10:34 a.m. Suggest removal
Economist says...
Please enlighten us with links to the litigation of which you speak.
Posted 30 March 2021, 2:02 p.m. Suggest removal
tribanon says...
Do your own homework.
Posted 30 March 2021, 8:29 p.m. Suggest removal
rosiepi says...
Sorry but no, AstraZeneca is the only Big Pharma entity that pledged from the outset to cut their profit margins until the pandemic was over, last year before their vaccine was developed and/or deemed successful, and costs unknown they entered contracts to sell their vaccines at $4@, $3 for poorer countries.
If they had set the price equal to Moderna's at $28@, a 300 billion vaccine contract would have cost $84 billion, Pfizer's at $15@, $45 billion, not AZ's price of $1.2 billion The WHO rightly said they developed 'a vaccine for the world'.
But yes, The Bahamas government should definitely at least stop giving the vaccines to those under 50 the age group affected with deadly side effects, new data shows the efficacy in those over 50 rises from 76% to 85%.
I will not be taking this vaccine but disinformation is dangerous.
Posted 30 March 2021, 2:22 p.m. Suggest removal
rosiepi says...
It is not just a matter of the cases of CVST in Europe, it is rather a vaccine-induced systemic blood disorder, now the UK and a host of other countries are reporting and investigating more cases and deaths.
The Atlantic has an enlightening article on the dangers and of mislabeling this syndrome. The heightened alerts are based on new cases/data, but the study quoted found that "though all were healthy before they developed a highly unusual, seemingly contradictory mix of blood disorders: clots throughout the body along with low numbers of platelets, the blood cells that help clots form. In a follow-up article published on Saturday, Vogel and Kupferschmidt cited a German researcher who has named the syndrome “vaccine-induced prothrombotic immune thrombocytopenia,” or VIPIT... the prothrombotic immune thrombocytopenia problem had already been recast in the English-language media as simply one of “blood clots... Seen in that context, the decisions to suspend the AstraZeneca rollout were puzzling—and perhaps, as some maintained, driven more by emotions than by data. The European Medicines Agency had helped create this impression"...but "These generic blood-clot data turned out to have little to do with the very specific, potential risks that several countries were confronting. The EMA said on March 18 that it had found, by then, a possible link to the AstraZeneca vaccine among 25 people who had developed the disturbing blood disorder, including nine who had died from it. All 25 had low platelet counts. Seven also had blood clots throughout their blood vessels—a condition known as disseminated intravascular coagulation, which showed up here at about five times the generally expected rate. The rest had blood clots that prevented blood from draining from their brain—a condition known as cerebral venous sinus thrombosis, which occurred at about nine times the expected rate. Also on March 18, the vaccine authority in the U.K. reported that it was investigating five cases of those cerebral clots in people with low platelets."
https://www.theatlantic.com/health/arch…
Posted 30 March 2021, 2:47 p.m. Suggest removal
DWW says...
tri-silly? China is using a different vaccine from the rest of the world. the developed their own which is being used in Brazil. They are not using the english patent version. if your going to make sweeping generalizations, please at least try to make them accurate.
Posted 30 March 2021, 8:33 a.m. Suggest removal
tribanon says...
Wrong. Canada's supply of the AstraZeneca vaccine was sourced from the US where it has not been approved by the FDA for emergency use.
Posted 30 March 2021, 10:09 a.m. Suggest removal
Log in to comment